FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023166257> ?p ?o ?g. }

• W2023166257 endingPage "1710" @default.
• W2023166257 startingPage "1701" @default.
• W2023166257 abstract "Specific ligands of the peripheral benzodiazepine receptor (PBR) activate pro-apoptotic and anti-proliferative signaling pathways. Previously, we found that PBR ligands activated the p38 mitogen-activated protein kinase (MAPK) pathway in esophageal cancer cells, and that the activation of p38MAPK contributed to tumor cell apoptosis and cell cycle arrest. Here, we report that PBR ligands also activate the pro-survival MAPK/ERK kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway in esophageal cancer cells, which might compromise the efficacy of PBR ligands. Hence, a combination treatment of PBR ligands and MEK inhibitors, which are emerging as promising anticancer agents, was pursued to determine whether this treatment could lead to enhanced apoptosis and cell cycle arrest. Using Western blotting we demonstrated a time- and dose-dependent phosphorylation of ERK1/2 in response to PBR ligands. Apoptosis was investigated by assessment of mitochondrial alterations and caspase-3 activity. Cell cycle arrest was measured by flow cytometric analysis of stained isolated nuclei. The inhibition of MEK/ERK with a pharmacologic inhibitor, 2′-amino-3′-methoxyflavone (PD 98059), resulted in a synergistic enhancement of PBR-ligand-induced growth inhibition, apoptosis and cell cycle arrest. Specifity of the pharmacologic inhibitor was confirmed by the use of 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U 0126), a second MEK/ERK inhibitor, and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U 0124), a structural analogue of it which does not display any affinity to MEK. Enhanced pro-apoptotic and anti-proliferative effects were observed both in KYSE-140 esophageal squamous cancer and OE-33 adenocarcinoma cells, suggesting that this effect was not cell-type specific. In addition, the PBR-mediated overexpression of the stress response gene (growth arrest and DNA-damage-inducible gene gadd153) was synergistically enhanced by MEK inhibition. This is the first report of enhanced PBR-ligand-mediated apoptosis and cell cycle arrest by simultaneous MEK inhibition, suggesting a new anticancer strategy." @default.
• W2023166257 created "2016-06-24" @default.
• W2023166257 creator A5016448185 @default.
• W2023166257 creator A5031972677 @default.
• W2023166257 creator A5036495825 @default.
• W2023166257 creator A5070546952 @default.
• W2023166257 creator A5072748450 @default.
• W2023166257 creator A5074379435 @default.
• W2023166257 date "2004-05-01" @default.
• W2023166257 modified "2023-10-01" @default.
• W2023166257 title "Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase" @default.
• W2023166257 cites W1122626307 @default.
• W2023166257 cites W1536041849 @default.
• W2023166257 cites W1583472519 @default.
• W2023166257 cites W163807256 @default.
• W2023166257 cites W1807206695 @default.
• W2023166257 cites W1864201493 @default.
• W2023166257 cites W1970399739 @default.
• W2023166257 cites W1971839532 @default.
• W2023166257 cites W1971915141 @default.
• W2023166257 cites W1972857272 @default.
• W2023166257 cites W1976385326 @default.
• W2023166257 cites W1980516021 @default.
• W2023166257 cites W1982904143 @default.
• W2023166257 cites W1985130451 @default.
• W2023166257 cites W1991225099 @default.
• W2023166257 cites W1996401496 @default.
• W2023166257 cites W1999627040 @default.
• W2023166257 cites W2010968880 @default.
• W2023166257 cites W2029420654 @default.
• W2023166257 cites W2031999073 @default.
• W2023166257 cites W2035147784 @default.
• W2023166257 cites W2035722698 @default.
• W2023166257 cites W2046104345 @default.
• W2023166257 cites W2059028043 @default.
• W2023166257 cites W2064047613 @default.
• W2023166257 cites W2069839886 @default.
• W2023166257 cites W2072489106 @default.
• W2023166257 cites W2077309295 @default.
• W2023166257 cites W2079494240 @default.
• W2023166257 cites W2084200016 @default.
• W2023166257 cites W2086262311 @default.
• W2023166257 cites W2090223182 @default.
• W2023166257 cites W2100403180 @default.
• W2023166257 cites W2117049476 @default.
• W2023166257 cites W2124221273 @default.
• W2023166257 cites W2127150495 @default.
• W2023166257 cites W2166624257 @default.
• W2023166257 cites W2320795531 @default.
• W2023166257 cites W2327027129 @default.
• W2023166257 cites W2396340985 @default.
• W2023166257 cites W2408244426 @default.
• W2023166257 cites W2019621874 @default.
• W2023166257 doi "https://doi.org/10.1016/j.bcp.2004.01.009" @default.
• W2023166257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15081869" @default.
• W2023166257 hasPublicationYear "2004" @default.
• W2023166257 type Work @default.
• W2023166257 sameAs 2023166257 @default.
• W2023166257 citedByCount "28" @default.
• W2023166257 countsByYear W20231662572012 @default.
• W2023166257 countsByYear W20231662572013 @default.
• W2023166257 countsByYear W20231662572014 @default.
• W2023166257 countsByYear W20231662572015 @default.
• W2023166257 countsByYear W20231662572016 @default.
• W2023166257 countsByYear W20231662572017 @default.
• W2023166257 countsByYear W20231662572018 @default.
• W2023166257 countsByYear W20231662572020 @default.
• W2023166257 countsByYear W20231662572022 @default.
• W2023166257 crossrefType "journal-article" @default.
• W2023166257 hasAuthorship W2023166257A5016448185 @default.
• W2023166257 hasAuthorship W2023166257A5031972677 @default.
• W2023166257 hasAuthorship W2023166257A5036495825 @default.
• W2023166257 hasAuthorship W2023166257A5070546952 @default.
• W2023166257 hasAuthorship W2023166257A5072748450 @default.
• W2023166257 hasAuthorship W2023166257A5074379435 @default.
• W2023166257 hasConcept C105696609 @default.
• W2023166257 hasConcept C121608353 @default.
• W2023166257 hasConcept C184235292 @default.
• W2023166257 hasConcept C185592680 @default.
• W2023166257 hasConcept C190283241 @default.
• W2023166257 hasConcept C2781249067 @default.
• W2023166257 hasConcept C29537977 @default.
• W2023166257 hasConcept C502942594 @default.
• W2023166257 hasConcept C51551487 @default.
• W2023166257 hasConcept C54355233 @default.
• W2023166257 hasConcept C55493867 @default.
• W2023166257 hasConcept C57074206 @default.
• W2023166257 hasConcept C62112901 @default.
• W2023166257 hasConcept C86803240 @default.
• W2023166257 hasConcept C95444343 @default.
• W2023166257 hasConcept C96232424 @default.
• W2023166257 hasConcept C97029542 @default.
• W2023166257 hasConceptScore W2023166257C105696609 @default.
• W2023166257 hasConceptScore W2023166257C121608353 @default.
• W2023166257 hasConceptScore W2023166257C184235292 @default.
• W2023166257 hasConceptScore W2023166257C185592680 @default.
• W2023166257 hasConceptScore W2023166257C190283241 @default.
• W2023166257 hasConceptScore W2023166257C2781249067 @default.

• next